Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma

Translational Oncology(2020)10.1016/j.tranon.2020.100805Source: DataRank Database

MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma is a research paper published in Translational Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.35)OA: goldTopics (24)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Dachen Zhou,Qiang Du ORCID,Peiqi Wan ORCID,Kun Dong ORCID,Hui Hou

Live enrichment

PubMed:32563177 PMC:PMC7305444 OpenAlex:https://openalex.org/W3036343500

Foundation for the National Institutes of Health

Natural Science Foundation of Anhui Province

Anhui Department of Education

FWCI

0.35

Citation Percentile

0.5%

Citation Trend

2020

2021

2022

2023

2024

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.tranon.2020.100805

GOLDhttps://doi.org/10.1016/j.tranon.2020.100805

publisherhttps://doi.org/10.1016/j.tranon.2020.100805

publisherhttps://api.elsevier.com/content/article/PII:S1936523320303004?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1936523320303004?httpAccept=text/plain

Fields of Study

MicroRNA in disease regulationCancer-related molecular mechanisms researchRNA modifications and cancerMedicineChemistry

Keywords

DoxorubicinCancer researchHepatocellular carcinomaCytotoxicitymicroRNALiver cancerPharmacologyCancer cellCell growthCell cultureCancerChemistryMedicineBiologyChemotherapyIn vitroInternal medicineBiochemistryGene

Sustainable Development Goals

SDG 0: Good health and well-being